Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Iterative Health in Katy, TX is seeking a Clinical Research Coordinator II to manage industry sponsored trials at a community site from startup through closeout. You will coordinate visit schedules, conduct consent talks, perform lab work and data entry, and maintain clean documentation for monitors and audits.
The role emphasizes patient interaction and protocol adherence, with growing exposure to CTMS and EDC systems as trials accelerate through activation and enrollment.
This role runs industry sponsored trials at a community site, from startup through closeout, largely on its own. A strong candidate has several years of hands on research or clinic experience, can handle visit schedules, consent talks, lab work and data entry, and keeps documentation clean for monitors and audits. Comfort with protocols, CTMS and EDC systems matters more than supervision.
How it fits the AI era
Much of the record keeping, query chasing and enrollment tracking can be sped up by software, so the coordinator spends less time on paperwork. What stays human is the patient relationship, the consent conversation, the clinical procedures and the judgment calls when a protocol question comes up. The role sits where trial operations meet tools that make sites faster.
How it builds AI experience
Working here means seeing how a technology company runs trials inside community clinics, so the coordinator picks up practical exposure to systems that speed site activation and enrollment. Building on that means getting fluent with CTMS and EDC platforms and learning how trial data flows from visit to sponsor. Experience in gastroenterology, hepatology or cardiology studies would add depth.
Worth showing
This is our own read, written from the employer's posting and the company's Spotlight. The employer's posting is the source of truth for the role.
About Iterative Health
Iterative Health embeds clinical research into community care settings, and per the company, runs trials 2x faster to activate sites and 3x higher patient enrollment.